Thirty years ago, the landscape of MRI research and clinical trials was a very different world compared to the complex regulatory environment we navigate today. Back then, conducting an MR study required little a few A4 page sized proposal submitted to the local ethics committee here in Bern. It was a time when innovation flourished with minimal administrative overhead, and trust in the expertise of researchers played a central role in ensuring safety and ethical/legal compliance.
The Simplicity of Early Ethics Submissions
In those days, proposing an MRI study was refreshingly straightforward:
- The ethics proposal often consisted of a brief description of the study’s purpose, methods, and intended participants.
- Local ethics committees relied on the knowledge and professional judgment of researchers to guarantee the safety of patients or test persons.
For systematic application of experimental procedures, an ethics proposal was still required. However, the process was fast, pragmatic, and trusted researchers to understand and mitigate risks associated with the experimental methods.
Freedom to Innovate in Pulse Sequences
Pulse sequence development, now a heavily regulated activity, was once an open playground for creativity. Researchers could design, test, and modify sequences without facing the strict oversight that characterizes modern regulatory frameworks. This freedom allowed for rapid technological advancements and contributed significantly to the growth of MRI as a clinical and research tool.
Experimental RF Coils and Hardware
Similarly, the use of experimental RF hardware or other devices on patients was managed with much less bureaucracy. While an ethics proposal was required for systematic use, the responsibility for patient and test person safety largely rested with individuals deeply familiar with MRI technology. This reliance on professional expertise rather than exhaustive documentation underscored a trust-based approach to research oversight.
A Shift in Responsibility
In the past, ensuring safety wasn’t about ticking regulatory boxes and writing an endless number of documents; it was about a personal and professional commitment to ethical research practices. Engineers, physicists, and clinicians involved in MRI studies were expected to take full accountability for the safety and efficacy of their work. Their hands-on expertise and direct involvement with the technology created a solid foundation for safe and ethical research.
From Past Simplicity to Present Complexity
Reflecting on this era of research, it’s clear that while patient safety and ethical practices were always priorities, the mechanisms to ensure them have evolved dramatically. The straightforward processes of the past have given way to intricate regulatory frameworks like Swissmedic and competent agencies within EU-MDR framework, requiring extensive documentation, risk analysis, data protection and compliance with a large number international standards.
The Journey Through the Regulatory Jungle
My own journey illustrates the increasing complexity of these processes. From October 2022 till November 2024, I spent 25 months navigating the intricate requirements of Swissmedic and the Cantonal Ethics Committee of Bern (KEK-Bern) for the approval of a research study. Of this, seven months were dedicated full-time to understanding and meeting the regulatory demands.
To put this outrageous amount of time into perspective:
- In 2012, I needed just two weeks of full-time work for a comparable KEK-Bern ethics approval.
- Following the implementation of the Human Research Act (HRA, SR 810.30) in Switzerland, the workload increased significantly. For a similar study, I required two months of full-time work to meet the new legal and ethical requirements.
These personal experiences highlight how regulatory frameworks, while crucial for safeguarding participants, have become significantly more demanding over time. This blog is inspired by those challenges. By sharing my journey, I hope to guide and support other researchers in the field of MRI, simplifying the path through the regulatory maze and empowering them to focus on the science and innovation that drive our work.